Compositions for adjuvant therapy of lung cancer, their preparation methods and applications
By preparing a composition containing traditional Chinese medicines such as mulberry, the problem of recurrence and metastasis in the treatment of lung cancer has been solved, and effective inhibition of lung cancer cells has been achieved, providing a safe adjuvant treatment option.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BEIJING CAPITALBIO PHARMA CO LTD
- Filing Date
- 2023-11-01
- Publication Date
- 2026-06-30
AI Technical Summary
Current treatments for lung cancer lack effective strategies for preventing recurrence and metastasis, and modern medical treatments can damage normal cells. Traditional Chinese medicine, with its synergistic effects across multiple pathways and targets, can be helpful as an adjunct therapy for lung cancer.
A traditional Chinese medicine composition is provided, consisting of mulberry, amla, nutmeg, euryale seed, rose, bamboo leaf, chrysanthemum, water chestnut, cinnamon, citron, clove and papaya, which is prepared into freeze-dried powder by water extraction and freeze-drying, and is used to prepare drugs or food therapy products for adjuvant treatment of lung cancer, inhibiting the proliferation and migration of lung cancer cells.
This traditional Chinese medicine composition has significant cell-killing and migration-inhibiting effects on human lung cancer cells A549, which can slow down the progression of lung cancer, improve symptoms, and provide long-term intervention and treatment effects.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3